These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 30967432)
1. Predicting Islet Cell Autoimmunity and Type 1 Diabetes: An 8-Year TEDDY Study Progress Report. Krischer JP; Liu X; Vehik K; Akolkar B; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Lernmark Å; Diabetes Care; 2019 Jun; 42(6):1051-1060. PubMed ID: 30967432 [TBL] [Abstract][Full Text] [Related]
2. Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY children. Jacobsen LM; Larsson HE; Tamura RN; Vehik K; Clasen J; Sosenko J; Hagopian WA; She JX; Steck AK; Rewers M; Simell O; Toppari J; Veijola R; Ziegler AG; Krischer JP; Akolkar B; Haller MJ; Pediatr Diabetes; 2019 May; 20(3):263-270. PubMed ID: 30628751 [TBL] [Abstract][Full Text] [Related]
3. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years. Pöllänen PM; Ryhänen SJ; Toppari J; Ilonen J; Vähäsalo P; Veijola R; Siljander H; Knip M J Clin Endocrinol Metab; 2020 Dec; 105(12):e4638-51. PubMed ID: 32882033 [TBL] [Abstract][Full Text] [Related]
4. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk. Redondo MJ; Geyer S; Steck AK; Sharp S; Wentworth JM; Weedon MN; Antinozzi P; Sosenko J; Atkinson M; Pugliese A; Oram RA; Diabetes Care; 2018 Sep; 41(9):1887-1894. PubMed ID: 30002199 [TBL] [Abstract][Full Text] [Related]
5. Hierarchical Order of Distinct Autoantibody Spreading and Progression to Type 1 Diabetes in the TEDDY Study. Vehik K; Bonifacio E; Lernmark Å; Yu L; Williams A; Schatz D; Rewers M; She JX; Toppari J; Hagopian W; Akolkar B; Ziegler AG; Krischer JP; Diabetes Care; 2020 Sep; 43(9):2066-2073. PubMed ID: 32641373 [TBL] [Abstract][Full Text] [Related]
6. Antibodies to oxidized insulin improve prediction of type 1 diabetes in children with positive standard islet autoantibodies. Strollo R; Vinci C; Napoli N; Fioriti E; Maddaloni E; Åkerman L; Casas R; Pozzilli P; Ludvigsson J; Nissim A Diabetes Metab Res Rev; 2019 May; 35(4):e3132. PubMed ID: 30693639 [TBL] [Abstract][Full Text] [Related]
7. First-appearing islet autoantibodies for type 1 diabetes in young children: maternal life events during pregnancy and the child's genetic risk. Johnson SB; Lynch KF; Roth R; Lundgren M; Parikh HM; Akolkar B; Hagopian W; Krischer J; Rewers M; She JX; Toppari J; Ziegler AG; Lernmark Å; Diabetologia; 2021 Mar; 64(3):591-602. PubMed ID: 33404683 [TBL] [Abstract][Full Text] [Related]
8. Identification of non-HLA genes associated with development of islet autoimmunity and type 1 diabetes in the prospective TEDDY cohort. Sharma A; Liu X; Hadley D; Hagopian W; Chen WM; Onengut-Gumuscu S; Törn C; Steck AK; Frohnert BI; Rewers M; Ziegler AG; Lernmark Å; Toppari J; Krischer JP; Akolkar B; Rich SS; She JX; J Autoimmun; 2018 May; 89():90-100. PubMed ID: 29310926 [TBL] [Abstract][Full Text] [Related]
9. Investigation of the vitamin D receptor gene (VDR) and its interaction with protein tyrosine phosphatase, non-receptor type 2 gene (PTPN2) on risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY). Frederiksen B; Liu E; Romanos J; Steck AK; Yin X; Kroehl M; Fingerlin TE; Erlich H; Eisenbarth GS; Rewers M; Norris JM J Steroid Biochem Mol Biol; 2013 Jan; 133():51-7. PubMed ID: 22960018 [TBL] [Abstract][Full Text] [Related]
10. Role of Type 1 Diabetes-Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study. Törn C; Hadley D; Lee HS; Hagopian W; Lernmark Å; Simell O; Rewers M; Ziegler A; Schatz D; Akolkar B; Onengut-Gumuscu S; Chen WM; Toppari J; Mykkänen J; Ilonen J; Rich SS; She JX; Steck AK; Krischer J; Diabetes; 2015 May; 64(5):1818-29. PubMed ID: 25422107 [TBL] [Abstract][Full Text] [Related]
11. Predictors of the Initiation of Islet Autoimmunity and Progression to Multiple Autoantibodies and Clinical Diabetes: The TEDDY Study. Krischer JP; Liu X; Lernmark Å; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Akolkar B; Diabetes Care; 2022 Oct; 45(10):2271-2281. PubMed ID: 36150053 [TBL] [Abstract][Full Text] [Related]
12. Intake of B vitamins and the risk of developing islet autoimmunity and type 1 diabetes in the TEDDY study. Hakola L; Mramba LK; Uusitalo U; Andrén Aronsson C; Hummel S; Niinistö S; Erlund I; Yang J; Rewers MJ; Akolkar B; McIndoe RA; Rich SS; Hagopian WA; Ziegler A; Lernmark Å; Toppari J; Krischer JP; Norris JM; Virtanen SM; Eur J Nutr; 2024 Jun; 63(4):1329-1338. PubMed ID: 38413484 [TBL] [Abstract][Full Text] [Related]
13. Improving prediction of type 1 diabetes by testing non-HLA genetic variants in addition to HLA markers. Steck AK; Dong F; Wong R; Fouts A; Liu E; Romanos J; Wijmenga C; Norris JM; Rewers MJ Pediatr Diabetes; 2014 Aug; 15(5):355-62. PubMed ID: 25075402 [TBL] [Abstract][Full Text] [Related]
14. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility. Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254 [TBL] [Abstract][Full Text] [Related]
15. Genetic and Environmental Interactions Modify the Risk of Diabetes-Related Autoimmunity by 6 Years of Age: The TEDDY Study. Krischer JP; Lynch KF; Lernmark Å; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Akolkar B; Diabetes Care; 2017 Sep; 40(9):1194-1202. PubMed ID: 28646072 [TBL] [Abstract][Full Text] [Related]
16. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children. Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086 [TBL] [Abstract][Full Text] [Related]
17. Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population. Kimpimäki T; Kulmala P; Savola K; Kupila A; Korhonen S; Simell T; Ilonen J; Simell O; Knip M J Clin Endocrinol Metab; 2002 Oct; 87(10):4572-9. PubMed ID: 12364437 [TBL] [Abstract][Full Text] [Related]
18. Evidence of stage- and age-related heterogeneity of non-HLA SNPs and risk of islet autoimmunity and type 1 diabetes: the diabetes autoimmunity study in the young. Frederiksen BN; Steck AK; Kroehl M; Lamb MM; Wong R; Rewers M; Norris JM Clin Dev Immunol; 2013; 2013():417657. PubMed ID: 24367383 [TBL] [Abstract][Full Text] [Related]
19. Plasma Metabolome and Circulating Vitamins Stratified Onset Age of an Initial Islet Autoantibody and Progression to Type 1 Diabetes: The TEDDY Study. Li Q; Liu X; Yang J; Erlund I; Lernmark Å; Hagopian W; Rewers M; She JX; Toppari J; Ziegler AG; Akolkar B; Krischer JP; Diabetes; 2021 Jan; 70(1):282-292. PubMed ID: 33106256 [TBL] [Abstract][Full Text] [Related]
20. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group. Sabbah E; Savola K; Kulmala P; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Ilonen J; Akerblom HK; Knip M Clin Exp Immunol; 1999 Apr; 116(1):78-83. PubMed ID: 10209508 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]